文献速递脑血管病

后大脑动脉卒中的取栓术与药物治疗比较:系统综述、荟萃分析与真实世界数据

Thrombectomy vs Medical Management for Posterior Cerebral Artery Stroke: Systematic Review, Meta-Analysis, and Real-World Data.
PubMed 文献 · Neurology · 2024-04-16

该系统综述与荟萃分析纳入5项队列研究共2095例后大脑动脉卒中患者,比较血管内取栓与药物治疗。取栓与90天无残疾几率更高相关(OR 1.25),但与功能独立无显著关联,且与症状性颅内出血几率更高相关(OR 2.48)。对美国国家住院患者样本95,585例的倾向评分匹配分析显示,取栓与良好出院结局率更低、院内死亡率更高相关;但在中重度卒中(NIHSS≥5分)患者中,取栓与良好结局率更高相关。

要点

  • 荟萃分析显示取栓与90天无残疾几率更高相关(OR 1.25,95%CI 1.04-1.50),但与功能独立无显著关联。
  • 取栓与症状性颅内出血几率更高相关(OR 2.48,95%CI 1.55-3.97),死亡几率数值上更高但未达统计学显著。
  • 真实世界数据显示取栓与良好出院结局率更低相关,但在中重度卒中患者中与良好结局率更高相关。

核心结论

  • 荟萃分析显示取栓可能有效减轻后大脑动脉卒中导致的致残性缺损,但与功能独立无不同几率相关,并可能与症状性颅内出血几率更高相关。
  • 这些发现被美国大型倾向评分匹配的真实世界数据分析所证实。
  • 作者认为后大脑动脉取栓决策应针对每位患者仔细个体化,未来需要随机试验进一步探索取栓的疗效与安全性。

研究设计与样本

  • 系统综述与荟萃分析:检索MEDLINE、Embase和Web of Science数据库,纳入比较取栓与药物治疗后大脑动脉卒中的良好实施队列研究,共5项研究2095例患者(取栓685例,药物治疗1410例)。
  • 真实世界数据:对2016-2020年美国国家住院患者样本中95,585例后大脑动脉卒中患者进行倾向评分匹配分析,其中取栓1540例。
  • 证据等级按牛津循证医学中心标准确定。

主要发现

  • 荟萃分析:取栓与90天无残疾几率更高相关(OR 1.25,95%CI 1.04-1.50,p=0.015),但与功能独立无显著关联(OR 0.87,95%CI 0.72-1.07,p=0.18)。
  • 荟萃分析:取栓与症状性颅内出血几率更高相关(OR 2.48,95%CI 1.55-3.97,p<0.001),死亡几率数值上更高但未达统计学显著(OR 1.32,95%CI 0.73-2.38,p=0.35)。
  • 倾向评分匹配分析:取栓组良好出院结局率24.4% vs 药物治疗组30.7%(p=0.037),取栓组更低。
  • 倾向评分匹配分析:取栓组院内死亡率8.8% vs 药物治疗组4.9%(p=0.021),取栓组更高;取栓组颅内出血率18.2% vs 药物治疗组11.7%(p=0.008),取栓组更高;取栓组蛛网膜下腔出血率3.9% vs 药物治疗组0.6%(p<0.001),取栓组更高。
  • 倾向评分匹配分析中,中重度卒中患者(NIHSS评分≥5分):取栓组良好结局率21.7% vs 药物治疗组13.8%(p=0.023),取栓组更高;死亡率7.6% vs 6.6%(p=0.67)及颅内出血率17.8% vs 13.1%(p=0.18)两组相似。

临床怎么用

  • 作者认为,后大脑动脉取栓的决策应针对每位患者仔细个体化。
  • 作者指出,未来需要随机试验进一步探索取栓治疗后大脑动脉卒中的疗效与安全性。

局限性

  • 未来需要随机试验进一步探索取栓治疗后大脑动脉卒中的疗效与安全性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: There is a paucity of high-level evidence for endovascular thrombectomy (EVT) in posterior cerebral artery (PCA) strokes. METHODS: The MEDLINE, Embase, and Web of Science databases were queried for well-conducted cohort studies comparing EVT vs medical management (MM) for PCA strokes. Outcomes of interest included 90-day functional outcomes, symptomatic intracranial hemorrhage (sICH), and death. The level of evidence was determined per the Oxford Centre for Evidence-Based Medicine criteria. We also conducted a propensity score matched (PSM) analysis of the 2016-2020 National Inpatient Sample (NIS) to provide support for our findings with real-world data. RESULTS: A total of 2,095 patients (685 EVT and 1,410 MM) were identified across 5 well-conducted cohort studies. EVT was significantly associated with higher odds of no disability at 90 days (odds ratio [OR] 1.25, 95% CI 1.04-1.50, p = 0.015) but not functional independence (OR 0.87, 95% CI 0.72-1.07, p = 0.18). EVT was also associated with higher odds of sICH (OR 2.48, 95% CI 1.55-3.97, p < 0.001) and numerically higher odds of death (OR 1.32, 95% CI 0.73-2.38; p = 0.35). PSM analysis of 95,585 PCA stroke patients in the NIS showed that EVT (n = 1,540) was associated with lower rates of good discharge outcomes (24.4% vs 30.7%, p = 0.037), higher rates of in-hospital mortality (8.8% vs 4.9%, p = 0.021), higher rates of ICH (18.2% and 11.7%, p = 0.008), and higher rates of subarachnoid hemorrhage (3.9% vs 0.6%, p < 0.001). Among patients with moderate to severe strokes (NIH Stroke Scale 5 or greater), EVT was associated with significantly higher rates of good outcomes (21.7% vs 13.8%, p = 0.023) with similar rates of mortality (7.6% vs 6.6%, p = 0.67) and ICH (17.8% vs, 13.1%, p = 0.18). DISCUSSION: Our meta-analysis revealed that while EVT may be effective in alleviating disabling deficits due to PCA strokes, it is not associated with different odds of functional independence and may be associated with higher odds of sICH. These findings were corroborated by our large propensity score matched analysis of real-world data in the United States. Thus, the decision to pursue PCA thrombectomies should be carefully individualized for each patient. Future randomized trials are needed to further explore the efficacy and safety of EVT for the treatment of PCA strokes. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that in patients with acute PCA ischemic stroke, treatment with EVT compared with MM alone was associated with higher odds of no disabling deficit at 90 days and higher odds of sICH.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Chen H, Khunte M, Colasurdo M, et al. Thrombectomy vs Medical Management for Posterior Cerebral Artery Stroke: Systematic Review, Meta-Analysis, and Real-World Data. Neurology. 2024. PMID: 38626383. doi:10.1212/WNL.0000000000209315

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。